nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—Toremifene—breast cancer	0.276	0.614	CrCtD
Phenoxybenzamine—Tamoxifen—breast cancer	0.173	0.386	CrCtD
Phenoxybenzamine—SLC22A3—Melphalan—breast cancer	0.054	0.363	CbGbCtD
Phenoxybenzamine—CYP3A4—breast cancer	0.0413	1	CbGaD
Phenoxybenzamine—Ospemifene—Toremifene—breast cancer	0.0324	0.117	CrCrCtD
Phenoxybenzamine—Clomifene—Toremifene—breast cancer	0.0324	0.117	CrCrCtD
Phenoxybenzamine—Clomifene—Tamoxifen—breast cancer	0.0204	0.0732	CrCrCtD
Phenoxybenzamine—Ospemifene—Tamoxifen—breast cancer	0.0204	0.0732	CrCrCtD
Phenoxybenzamine—SLC22A3—Irinotecan—breast cancer	0.0183	0.123	CbGbCtD
Phenoxybenzamine—Naftifine—Toremifene—breast cancer	0.0178	0.0641	CrCrCtD
Phenoxybenzamine—Tamoxifen—Toremifene—breast cancer	0.0148	0.0532	CrCrCtD
Phenoxybenzamine—Toremifene—Tamoxifen—breast cancer	0.0135	0.0486	CrCrCtD
Phenoxybenzamine—Dextropropoxyphene—Toremifene—breast cancer	0.0117	0.0423	CrCrCtD
Phenoxybenzamine—Naftifine—Tamoxifen—breast cancer	0.0112	0.0403	CrCrCtD
Phenoxybenzamine—SLC22A2—Vinblastine—breast cancer	0.00961	0.0647	CbGbCtD
Phenoxybenzamine—Levomethadyl Acetate—Tamoxifen—breast cancer	0.00899	0.0323	CrCrCtD
Phenoxybenzamine—Methadyl Acetate—Tamoxifen—breast cancer	0.00899	0.0323	CrCrCtD
Phenoxybenzamine—CYP3A4—Exemestane—breast cancer	0.00887	0.0597	CbGbCtD
Phenoxybenzamine—Clofedanol—Toremifene—breast cancer	0.00849	0.0305	CrCrCtD
Phenoxybenzamine—Orphenadrine—Toremifene—breast cancer	0.00822	0.0296	CrCrCtD
Phenoxybenzamine—Benzphetamine—Toremifene—breast cancer	0.00822	0.0296	CrCrCtD
Phenoxybenzamine—Benzyl Benzoate—Toremifene—breast cancer	0.00762	0.0274	CrCrCtD
Phenoxybenzamine—CYP3A4—Letrozole—breast cancer	0.00754	0.0507	CbGbCtD
Phenoxybenzamine—Dextropropoxyphene—Tamoxifen—breast cancer	0.00738	0.0265	CrCrCtD
Phenoxybenzamine—Diphenhydramine—Toremifene—breast cancer	0.0073	0.0263	CrCrCtD
Phenoxybenzamine—Tripelennamine—Tamoxifen—breast cancer	0.00703	0.0253	CrCrCtD
Phenoxybenzamine—CYP3A4—Anastrozole—breast cancer	0.00672	0.0452	CbGbCtD
Phenoxybenzamine—Methadone—Tamoxifen—breast cancer	0.00617	0.0222	CrCrCtD
Phenoxybenzamine—CYP3A4—Toremifene—breast cancer	0.00615	0.0414	CbGbCtD
Phenoxybenzamine—CYP3A4—Fulvestrant—breast cancer	0.00572	0.0385	CbGbCtD
Phenoxybenzamine—Clofedanol—Tamoxifen—breast cancer	0.00533	0.0192	CrCrCtD
Phenoxybenzamine—Orphenadrine—Tamoxifen—breast cancer	0.00516	0.0186	CrCrCtD
Phenoxybenzamine—Benzphetamine—Tamoxifen—breast cancer	0.00516	0.0186	CrCrCtD
Phenoxybenzamine—CYP3A4—Thiotepa—breast cancer	0.00509	0.0343	CbGbCtD
Phenoxybenzamine—Benzyl Benzoate—Tamoxifen—breast cancer	0.00478	0.0172	CrCrCtD
Phenoxybenzamine—CYP3A4—Ixabepilone—breast cancer	0.00466	0.0314	CbGbCtD
Phenoxybenzamine—Diphenhydramine—Tamoxifen—breast cancer	0.00458	0.0165	CrCrCtD
Phenoxybenzamine—CYP3A4—Lapatinib—breast cancer	0.00449	0.0302	CbGbCtD
Phenoxybenzamine—CYP3A4—Raloxifene—breast cancer	0.0034	0.0229	CbGbCtD
Phenoxybenzamine—CYP3A4—Vinorelbine—breast cancer	0.00249	0.0167	CbGbCtD
Phenoxybenzamine—CYP3A4—Tamoxifen—breast cancer	0.00225	0.0151	CbGbCtD
Phenoxybenzamine—CYP3A4—Mitoxantrone—breast cancer	0.00219	0.0147	CbGbCtD
Phenoxybenzamine—CYP3A4—Paclitaxel—breast cancer	0.00175	0.0118	CbGbCtD
Phenoxybenzamine—CYP3A4—Irinotecan—breast cancer	0.00172	0.0116	CbGbCtD
Phenoxybenzamine—CYP3A4—Vinblastine—breast cancer	0.00153	0.0103	CbGbCtD
Phenoxybenzamine—CYP3A4—Docetaxel—breast cancer	0.00126	0.0085	CbGbCtD
Phenoxybenzamine—CYP3A4—Doxorubicin—breast cancer	0.000942	0.00634	CbGbCtD
Phenoxybenzamine—CALM3—mammary gland—breast cancer	0.000502	0.034	CbGeAlD
Phenoxybenzamine—Miosis—Irinotecan—breast cancer	0.000419	0.063	CcSEcCtD
Phenoxybenzamine—CALM3—nipple—breast cancer	0.000416	0.0281	CbGeAlD
Phenoxybenzamine—CALM1—mammary gland—breast cancer	0.000393	0.0266	CbGeAlD
Phenoxybenzamine—SLC22A3—nipple—breast cancer	0.000384	0.026	CbGeAlD
Phenoxybenzamine—ADRA1D—epithelium—breast cancer	0.000359	0.0243	CbGeAlD
Phenoxybenzamine—Gastrointestinal tract irritation—Capecitabine—breast cancer	0.000328	0.0493	CcSEcCtD
Phenoxybenzamine—CALM2—nipple—breast cancer	0.000326	0.0221	CbGeAlD
Phenoxybenzamine—CALM1—nipple—breast cancer	0.000325	0.022	CbGeAlD
Phenoxybenzamine—SLC22A3—embryo—breast cancer	0.000317	0.0215	CbGeAlD
Phenoxybenzamine—ADRA2C—nipple—breast cancer	0.000292	0.0197	CbGeAlD
Phenoxybenzamine—CALM2—embryo—breast cancer	0.000269	0.0182	CbGeAlD
Phenoxybenzamine—CALM1—embryo—breast cancer	0.000268	0.0181	CbGeAlD
Phenoxybenzamine—ADRA1D—female reproductive system—breast cancer	0.000267	0.018	CbGeAlD
Phenoxybenzamine—CALM3—endometrium—breast cancer	0.000251	0.017	CbGeAlD
Phenoxybenzamine—ADRA2A—nipple—breast cancer	0.000233	0.0157	CbGeAlD
Phenoxybenzamine—SLC22A3—endometrium—breast cancer	0.000232	0.0157	CbGeAlD
Phenoxybenzamine—CALM3—uterus—breast cancer	0.000231	0.0156	CbGeAlD
Phenoxybenzamine—CALM3—pituitary gland—breast cancer	0.000227	0.0154	CbGeAlD
Phenoxybenzamine—CALM3—adipose tissue—breast cancer	0.000226	0.0153	CbGeAlD
Phenoxybenzamine—ADRA1D—endocrine gland—breast cancer	0.000226	0.0153	CbGeAlD
Phenoxybenzamine—CALM2—epithelium—breast cancer	0.00022	0.0149	CbGeAlD
Phenoxybenzamine—SLC22A1—adipose tissue—breast cancer	0.000219	0.0148	CbGeAlD
Phenoxybenzamine—CALM1—epithelium—breast cancer	0.000219	0.0148	CbGeAlD
Phenoxybenzamine—SLC22A3—adipose tissue—breast cancer	0.000209	0.0141	CbGeAlD
Phenoxybenzamine—CALM2—skin of body—breast cancer	0.000209	0.0141	CbGeAlD
Phenoxybenzamine—CALM1—skin of body—breast cancer	0.000208	0.0141	CbGeAlD
Phenoxybenzamine—ADRA1A—epithelium—breast cancer	0.000206	0.0139	CbGeAlD
Phenoxybenzamine—CALM3—adrenal gland—breast cancer	0.000203	0.0137	CbGeAlD
Phenoxybenzamine—CALM2—endometrium—breast cancer	0.000197	0.0133	CbGeAlD
Phenoxybenzamine—CALM3—bone marrow—breast cancer	0.000196	0.0133	CbGeAlD
Phenoxybenzamine—CALM1—endometrium—breast cancer	0.000196	0.0133	CbGeAlD
Phenoxybenzamine—SLC22A3—female reproductive system—breast cancer	0.000192	0.013	CbGeAlD
Phenoxybenzamine—Tamoxifen—ESRRA—breast cancer	0.00019	0.105	CrCbGaD
Phenoxybenzamine—CALM3—female gonad—breast cancer	0.000189	0.0128	CbGeAlD
Phenoxybenzamine—SLC22A3—adrenal gland—breast cancer	0.000188	0.0127	CbGeAlD
Phenoxybenzamine—CALM2—uterus—breast cancer	0.000182	0.0123	CbGeAlD
Phenoxybenzamine—CALM1—uterus—breast cancer	0.000181	0.0122	CbGeAlD
Phenoxybenzamine—CALM2—pituitary gland—breast cancer	0.000178	0.0121	CbGeAlD
Phenoxybenzamine—CALM2—adipose tissue—breast cancer	0.000178	0.012	CbGeAlD
Phenoxybenzamine—CALM1—pituitary gland—breast cancer	0.000177	0.012	CbGeAlD
Phenoxybenzamine—CALM1—adipose tissue—breast cancer	0.000177	0.012	CbGeAlD
Phenoxybenzamine—ADRA2C—endometrium—breast cancer	0.000176	0.0119	CbGeAlD
Phenoxybenzamine—SLC22A3—female gonad—breast cancer	0.000175	0.0118	CbGeAlD
Phenoxybenzamine—SLC22A1—endocrine gland—breast cancer	0.00017	0.0115	CbGeAlD
Phenoxybenzamine—ADRA1A—adipose tissue—breast cancer	0.000167	0.0113	CbGeAlD
Phenoxybenzamine—CALM2—female reproductive system—breast cancer	0.000163	0.011	CbGeAlD
Phenoxybenzamine—SLC22A3—endocrine gland—breast cancer	0.000163	0.011	CbGeAlD
Phenoxybenzamine—CALM1—female reproductive system—breast cancer	0.000162	0.011	CbGeAlD
Phenoxybenzamine—ADRA2C—uterus—breast cancer	0.000162	0.011	CbGeAlD
Phenoxybenzamine—ADRA2C—pituitary gland—breast cancer	0.000159	0.0108	CbGeAlD
Phenoxybenzamine—CALM2—adrenal gland—breast cancer	0.000159	0.0108	CbGeAlD
Phenoxybenzamine—ADRA2C—adipose tissue—breast cancer	0.000159	0.0107	CbGeAlD
Phenoxybenzamine—CALM1—adrenal gland—breast cancer	0.000159	0.0107	CbGeAlD
Phenoxybenzamine—Fatigue—Lapatinib—breast cancer	0.000157	0.0236	CcSEcCtD
Phenoxybenzamine—CALM2—bone marrow—breast cancer	0.000154	0.0104	CbGeAlD
Phenoxybenzamine—CALM1—bone marrow—breast cancer	0.000153	0.0104	CbGeAlD
Phenoxybenzamine—ADRA1A—adrenal gland—breast cancer	0.000149	0.0101	CbGeAlD
Phenoxybenzamine—Abdominal discomfort—Tamoxifen—breast cancer	0.000149	0.0224	CcSEcCtD
Phenoxybenzamine—CALM2—female gonad—breast cancer	0.000149	0.0101	CbGeAlD
Phenoxybenzamine—CALM1—female gonad—breast cancer	0.000148	0.01	CbGeAlD
Phenoxybenzamine—Fatigue—Fulvestrant—breast cancer	0.000145	0.0217	CcSEcCtD
Phenoxybenzamine—Tamoxifen—SULT1A1—breast cancer	0.000144	0.0796	CrCbGaD
Phenoxybenzamine—Fatigue—Toremifene—breast cancer	0.000143	0.0215	CcSEcCtD
Phenoxybenzamine—ADRA2C—adrenal gland—breast cancer	0.000142	0.00963	CbGeAlD
Phenoxybenzamine—ADRA2A—endometrium—breast cancer	0.000141	0.00951	CbGeAlD
Phenoxybenzamine—CALM2—endocrine gland—breast cancer	0.000138	0.00935	CbGeAlD
Phenoxybenzamine—CALM1—endocrine gland—breast cancer	0.000137	0.0093	CbGeAlD
Phenoxybenzamine—ADRA2C—female gonad—breast cancer	0.000133	0.00898	CbGeAlD
Phenoxybenzamine—Drowsiness—Goserelin—breast cancer	0.000133	0.0199	CcSEcCtD
Phenoxybenzamine—Asthenia—Lapatinib—breast cancer	0.000131	0.0197	CcSEcCtD
Phenoxybenzamine—ADRA1A—endocrine gland—breast cancer	0.00013	0.00877	CbGeAlD
Phenoxybenzamine—ADRA2A—uterus—breast cancer	0.000129	0.00876	CbGeAlD
Phenoxybenzamine—ADRA2A—pituitary gland—breast cancer	0.000127	0.0086	CbGeAlD
Phenoxybenzamine—ADRA2A—adipose tissue—breast cancer	0.000127	0.00857	CbGeAlD
Phenoxybenzamine—Tachycardia—Letrozole—breast cancer	0.000126	0.019	CcSEcCtD
Phenoxybenzamine—Fatigue—Exemestane—breast cancer	0.000126	0.0189	CcSEcCtD
Phenoxybenzamine—CALM3—lymph node—breast cancer	0.000122	0.00823	CbGeAlD
Phenoxybenzamine—Asthenia—Fulvestrant—breast cancer	0.00012	0.0181	CcSEcCtD
Phenoxybenzamine—Asthenia—Toremifene—breast cancer	0.000119	0.0179	CcSEcCtD
Phenoxybenzamine—Fatigue—Ixabepilone—breast cancer	0.000119	0.0178	CcSEcCtD
Phenoxybenzamine—ADRA2A—female reproductive system—breast cancer	0.000116	0.00788	CbGeAlD
Phenoxybenzamine—Orthostatic hypotension—Irinotecan—breast cancer	0.000116	0.0175	CcSEcCtD
Phenoxybenzamine—Somnolence—Anastrozole—breast cancer	0.000115	0.0173	CcSEcCtD
Phenoxybenzamine—Somnolence—Letrozole—breast cancer	0.000115	0.0173	CcSEcCtD
Phenoxybenzamine—Nasal congestion—Paclitaxel—breast cancer	0.000114	0.0171	CcSEcCtD
Phenoxybenzamine—ADRA2A—adrenal gland—breast cancer	0.000114	0.00769	CbGeAlD
Phenoxybenzamine—SLC22A3—lymph node—breast cancer	0.000112	0.00761	CbGeAlD
Phenoxybenzamine—Fatigue—Anastrozole—breast cancer	0.000112	0.0168	CcSEcCtD
Phenoxybenzamine—Fatigue—Letrozole—breast cancer	0.000112	0.0168	CcSEcCtD
Phenoxybenzamine—ADRA2A—female gonad—breast cancer	0.000106	0.00717	CbGeAlD
Phenoxybenzamine—Asthenia—Exemestane—breast cancer	0.000105	0.0157	CcSEcCtD
Phenoxybenzamine—Asthenia—Ixabepilone—breast cancer	9.86e-05	0.0148	CcSEcCtD
Phenoxybenzamine—ADRA2A—endocrine gland—breast cancer	9.85e-05	0.00667	CbGeAlD
Phenoxybenzamine—Drowsiness—Mitoxantrone—breast cancer	9.8e-05	0.0147	CcSEcCtD
Phenoxybenzamine—CALM2—lymph node—breast cancer	9.55e-05	0.00646	CbGeAlD
Phenoxybenzamine—CALM1—lymph node—breast cancer	9.5e-05	0.00643	CbGeAlD
Phenoxybenzamine—Orthostatic hypotension—Paclitaxel—breast cancer	9.47e-05	0.0142	CcSEcCtD
Phenoxybenzamine—Asthenia—Letrozole—breast cancer	9.29e-05	0.014	CcSEcCtD
Phenoxybenzamine—Asthenia—Anastrozole—breast cancer	9.29e-05	0.014	CcSEcCtD
Phenoxybenzamine—CYP3A4—female reproductive system—breast cancer	9.16e-05	0.0062	CbGeAlD
Phenoxybenzamine—Fatigue—Chlorambucil—breast cancer	8.58e-05	0.0129	CcSEcCtD
Phenoxybenzamine—ADRA2C—lymph node—breast cancer	8.53e-05	0.00577	CbGeAlD
Phenoxybenzamine—Tachycardia—Melphalan—breast cancer	8.47e-05	0.0127	CcSEcCtD
Phenoxybenzamine—Tachycardia—Goserelin—breast cancer	8.26e-05	0.0124	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Docetaxel—breast cancer	8.03e-05	0.0121	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Capecitabine—breast cancer	7.77e-05	0.0117	CcSEcCtD
Phenoxybenzamine—CYP3A4—endocrine gland—breast cancer	7.75e-05	0.00525	CbGeAlD
Phenoxybenzamine—Ospemifene—ESR1—breast cancer	7.68e-05	0.0424	CrCbGaD
Phenoxybenzamine—Fatigue—Tamoxifen—breast cancer	7.64e-05	0.0115	CcSEcCtD
Phenoxybenzamine—Somnolence—Goserelin—breast cancer	7.52e-05	0.0113	CcSEcCtD
Phenoxybenzamine—Fatigue—Melphalan—breast cancer	7.48e-05	0.0112	CcSEcCtD
Phenoxybenzamine—Tachycardia—Vinorelbine—breast cancer	7.4e-05	0.0111	CcSEcCtD
Phenoxybenzamine—Fatigue—Goserelin—breast cancer	7.29e-05	0.011	CcSEcCtD
Phenoxybenzamine—Asthenia—Chlorambucil—breast cancer	7.14e-05	0.0107	CcSEcCtD
Phenoxybenzamine—Tachycardia—Thiotepa—breast cancer	7.06e-05	0.0106	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Capecitabine—breast cancer	7.05e-05	0.0106	CcSEcCtD
Phenoxybenzamine—ADRA2A—lymph node—breast cancer	6.81e-05	0.00461	CbGeAlD
Phenoxybenzamine—Asthenia—Vinblastine—breast cancer	6.54e-05	0.00983	CcSEcCtD
Phenoxybenzamine—Fatigue—Vinorelbine—breast cancer	6.53e-05	0.00982	CcSEcCtD
Phenoxybenzamine—Somnolence—Thiotepa—breast cancer	6.43e-05	0.00967	CcSEcCtD
Phenoxybenzamine—Asthenia—Tamoxifen—breast cancer	6.36e-05	0.00955	CcSEcCtD
Phenoxybenzamine—Toremifene—ESR1—breast cancer	6.26e-05	0.0345	CrCbGaD
Phenoxybenzamine—Fatigue—Thiotepa—breast cancer	6.24e-05	0.00938	CcSEcCtD
Phenoxybenzamine—Asthenia—Melphalan—breast cancer	6.22e-05	0.00935	CcSEcCtD
Phenoxybenzamine—Tachycardia—Mitoxantrone—breast cancer	6.1e-05	0.00917	CcSEcCtD
Phenoxybenzamine—Asthenia—Goserelin—breast cancer	6.07e-05	0.00912	CcSEcCtD
Phenoxybenzamine—Clomifene—CYP19A1—breast cancer	5.88e-05	0.0324	CrCbGaD
Phenoxybenzamine—Tachycardia—Fluorouracil—breast cancer	5.84e-05	0.00878	CcSEcCtD
Phenoxybenzamine—Somnolence—Mitoxantrone—breast cancer	5.56e-05	0.00835	CcSEcCtD
Phenoxybenzamine—Somnolence—Irinotecan—breast cancer	5.56e-05	0.00835	CcSEcCtD
Phenoxybenzamine—Asthenia—Vinorelbine—breast cancer	5.44e-05	0.00817	CcSEcCtD
Phenoxybenzamine—Orthostatic hypotension—Epirubicin—breast cancer	5.42e-05	0.00814	CcSEcCtD
Phenoxybenzamine—Clomifene—ESR1—breast cancer	5.41e-05	0.0299	CrCbGaD
Phenoxybenzamine—Somnolence—Gemcitabine—breast cancer	5.41e-05	0.00814	CcSEcCtD
Phenoxybenzamine—Fatigue—Mitoxantrone—breast cancer	5.39e-05	0.0081	CcSEcCtD
Phenoxybenzamine—Fatigue—Irinotecan—breast cancer	5.39e-05	0.0081	CcSEcCtD
Phenoxybenzamine—Ethopropazine—BCHE—breast cancer	5.35e-05	0.0295	CrCbGaD
Phenoxybenzamine—Somnolence—Fluorouracil—breast cancer	5.32e-05	0.008	CcSEcCtD
Phenoxybenzamine—Abdominal discomfort—Methotrexate—breast cancer	5.25e-05	0.00789	CcSEcCtD
Phenoxybenzamine—Fatigue—Gemcitabine—breast cancer	5.25e-05	0.00789	CcSEcCtD
Phenoxybenzamine—Asthenia—Thiotepa—breast cancer	5.19e-05	0.0078	CcSEcCtD
Phenoxybenzamine—Fenoprofen—PTGS1—breast cancer	5.16e-05	0.0285	CrCbGaD
Phenoxybenzamine—Orthostatic hypotension—Doxorubicin—breast cancer	5.01e-05	0.00753	CcSEcCtD
Phenoxybenzamine—Toremifene—CYP1A1—breast cancer	5.01e-05	0.0276	CrCbGaD
Phenoxybenzamine—Tachycardia—Paclitaxel—breast cancer	4.97e-05	0.00748	CcSEcCtD
Phenoxybenzamine—Drowsiness—Methotrexate—breast cancer	4.88e-05	0.00734	CcSEcCtD
Phenoxybenzamine—Orphenadrine—SCN10A—breast cancer	4.7e-05	0.026	CrCbGaD
Phenoxybenzamine—Levomethadyl Acetate—CYP19A1—breast cancer	4.6e-05	0.0254	CrCbGaD
Phenoxybenzamine—Drowsiness—Epirubicin—breast cancer	4.57e-05	0.00687	CcSEcCtD
Phenoxybenzamine—Somnolence—Paclitaxel—breast cancer	4.53e-05	0.00681	CcSEcCtD
Phenoxybenzamine—Asthenia—Mitoxantrone—breast cancer	4.48e-05	0.00674	CcSEcCtD
Phenoxybenzamine—Asthenia—Irinotecan—breast cancer	4.48e-05	0.00674	CcSEcCtD
Phenoxybenzamine—Fatigue—Paclitaxel—breast cancer	4.39e-05	0.00661	CcSEcCtD
Phenoxybenzamine—Asthenia—Gemcitabine—breast cancer	4.37e-05	0.00657	CcSEcCtD
Phenoxybenzamine—Clomifene—CYP1A1—breast cancer	4.33e-05	0.0239	CrCbGaD
Phenoxybenzamine—Drowsiness—Doxorubicin—breast cancer	4.23e-05	0.00635	CcSEcCtD
Phenoxybenzamine—Tachycardia—Docetaxel—breast cancer	4.22e-05	0.00634	CcSEcCtD
Phenoxybenzamine—Phenylbutazone—PTGS1—breast cancer	4.13e-05	0.0228	CrCbGaD
Phenoxybenzamine—Tachycardia—Capecitabine—breast cancer	4.08e-05	0.00614	CcSEcCtD
Phenoxybenzamine—Tamoxifen—ESR2—breast cancer	4.06e-05	0.0224	CrCbGaD
Phenoxybenzamine—Ospemifene—CYP3A4—breast cancer	3.92e-05	0.0216	CrCbGaD
Phenoxybenzamine—Tripelennamine—CYP2D6—breast cancer	3.87e-05	0.0214	CrCbGaD
Phenoxybenzamine—Somnolence—Docetaxel—breast cancer	3.84e-05	0.00577	CcSEcCtD
Phenoxybenzamine—Fatigue—Docetaxel—breast cancer	3.72e-05	0.0056	CcSEcCtD
Phenoxybenzamine—Tamoxifen—CYP1B1—breast cancer	3.7e-05	0.0204	CrCbGaD
Phenoxybenzamine—Asthenia—Paclitaxel—breast cancer	3.66e-05	0.0055	CcSEcCtD
Phenoxybenzamine—Fatigue—Capecitabine—breast cancer	3.61e-05	0.00542	CcSEcCtD
Phenoxybenzamine—Toremifene—CYP3A4—breast cancer	3.2e-05	0.0176	CrCbGaD
Phenoxybenzamine—Asthenia—Docetaxel—breast cancer	3.1e-05	0.00466	CcSEcCtD
Phenoxybenzamine—Asthenia—Capecitabine—breast cancer	3e-05	0.00451	CcSEcCtD
Phenoxybenzamine—Fenoprofen—PTGS2—breast cancer	2.95e-05	0.0163	CrCbGaD
Phenoxybenzamine—Tachycardia—Epirubicin—breast cancer	2.84e-05	0.00427	CcSEcCtD
Phenoxybenzamine—Somnolence—Methotrexate—breast cancer	2.77e-05	0.00416	CcSEcCtD
Phenoxybenzamine—Clomifene—CYP3A4—breast cancer	2.76e-05	0.0152	CrCbGaD
Phenoxybenzamine—Tamoxifen—CYP19A1—breast cancer	2.72e-05	0.015	CrCbGaD
Phenoxybenzamine—Methadone—CYP19A1—breast cancer	2.69e-05	0.0149	CrCbGaD
Phenoxybenzamine—Fatigue—Methotrexate—breast cancer	2.68e-05	0.00404	CcSEcCtD
Phenoxybenzamine—Toremifene—ABCB1—breast cancer	2.66e-05	0.0147	CrCbGaD
Phenoxybenzamine—Tachycardia—Doxorubicin—breast cancer	2.63e-05	0.00396	CcSEcCtD
Phenoxybenzamine—Fenoprofen—ALB—breast cancer	2.63e-05	0.0145	CrCbGaD
Phenoxybenzamine—Propafenone—CYP2D6—breast cancer	2.63e-05	0.0145	CrCbGaD
Phenoxybenzamine—Somnolence—Epirubicin—breast cancer	2.59e-05	0.00389	CcSEcCtD
Phenoxybenzamine—Tamoxifen—ABCG2—breast cancer	2.55e-05	0.0141	CrCbGaD
Phenoxybenzamine—Fatigue—Epirubicin—breast cancer	2.51e-05	0.00378	CcSEcCtD
Phenoxybenzamine—Tamoxifen—ESR1—breast cancer	2.5e-05	0.0138	CrCbGaD
Phenoxybenzamine—Phenylbutazone—CYP3A4—breast cancer	2.41e-05	0.0133	CrCbGaD
Phenoxybenzamine—Somnolence—Doxorubicin—breast cancer	2.4e-05	0.0036	CcSEcCtD
Phenoxybenzamine—Phenylbutazone—PTGS2—breast cancer	2.36e-05	0.013	CrCbGaD
Phenoxybenzamine—Bepridil—CYP2D6—breast cancer	2.34e-05	0.0129	CrCbGaD
Phenoxybenzamine—Fatigue—Doxorubicin—breast cancer	2.32e-05	0.00349	CcSEcCtD
Phenoxybenzamine—Clomifene—ABCB1—breast cancer	2.3e-05	0.0127	CrCbGaD
Phenoxybenzamine—Propafenone—CYP3A4—breast cancer	2.25e-05	0.0124	CrCbGaD
Phenoxybenzamine—Diphenhydramine—PTGS1—breast cancer	2.25e-05	0.0124	CrCbGaD
Phenoxybenzamine—Asthenia—Methotrexate—breast cancer	2.23e-05	0.00336	CcSEcCtD
Phenoxybenzamine—Dextropropoxyphene—CYP2D6—breast cancer	2.18e-05	0.012	CrCbGaD
Phenoxybenzamine—Levomethadyl Acetate—CYP3A4—breast cancer	2.16e-05	0.0119	CrCbGaD
Phenoxybenzamine—Asthenia—Epirubicin—breast cancer	2.09e-05	0.00314	CcSEcCtD
Phenoxybenzamine—Tamoxifen—CYP1A1—breast cancer	2e-05	0.011	CrCbGaD
Phenoxybenzamine—Asthenia—Doxorubicin—breast cancer	1.93e-05	0.00291	CcSEcCtD
Phenoxybenzamine—Atomoxetine—CYP2D6—breast cancer	1.89e-05	0.0104	CrCbGaD
Phenoxybenzamine—Modafinil—CYP3A4—breast cancer	1.89e-05	0.0104	CrCbGaD
Phenoxybenzamine—Propafenone—ABCB1—breast cancer	1.87e-05	0.0103	CrCbGaD
Phenoxybenzamine—Dextropropoxyphene—CYP3A4—breast cancer	1.87e-05	0.0103	CrCbGaD
Phenoxybenzamine—Fentanyl—CYP3A4—breast cancer	1.85e-05	0.0102	CrCbGaD
Phenoxybenzamine—Bepridil—ABCB1—breast cancer	1.67e-05	0.00922	CrCbGaD
Phenoxybenzamine—Benzphetamine—CYP3A4—breast cancer	1.64e-05	0.00902	CrCbGaD
Phenoxybenzamine—Atomoxetine—CYP3A4—breast cancer	1.62e-05	0.00895	CrCbGaD
Phenoxybenzamine—Fentanyl—ABCB1—breast cancer	1.54e-05	0.00847	CrCbGaD
Phenoxybenzamine—Diphenhydramine—CYP2D6—breast cancer	1.53e-05	0.00843	CrCbGaD
Phenoxybenzamine—Tamoxifen—CYP2D6—breast cancer	1.49e-05	0.00821	CrCbGaD
Phenoxybenzamine—Methadone—CYP2D6—breast cancer	1.48e-05	0.00814	CrCbGaD
Phenoxybenzamine—Tamoxifen—CYP3A4—breast cancer	1.28e-05	0.00704	CrCbGaD
Phenoxybenzamine—Methadone—CYP3A4—breast cancer	1.27e-05	0.00698	CrCbGaD
Phenoxybenzamine—Orphenadrine—CYP3A4—breast cancer	1.24e-05	0.00684	CrCbGaD
Phenoxybenzamine—Tamoxifen—ABCB1—breast cancer	1.06e-05	0.00586	CrCbGaD
Phenoxybenzamine—Methadone—ABCB1—breast cancer	1.05e-05	0.00581	CrCbGaD
Phenoxybenzamine—CALM3—Signaling Pathways—RELA—breast cancer	5.87e-07	9.94e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PTEN—breast cancer	5.87e-07	9.93e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—AKT1—breast cancer	5.86e-07	9.91e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—EGFR—breast cancer	5.84e-07	9.89e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—ERBB2—breast cancer	5.84e-07	9.88e-06	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—PIK3CA—breast cancer	5.82e-07	9.86e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ABCB1—breast cancer	5.82e-07	9.85e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CASP3—breast cancer	5.81e-07	9.82e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL2—breast cancer	5.8e-07	9.81e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—EGFR—breast cancer	5.78e-07	9.77e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—EGFR—breast cancer	5.77e-07	9.76e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL6—breast cancer	5.77e-07	9.76e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PIK3CB—breast cancer	5.76e-07	9.75e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MTOR—breast cancer	5.76e-07	9.75e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PTEN—breast cancer	5.76e-07	9.74e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PTEN—breast cancer	5.76e-07	9.74e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—PIK3CA—breast cancer	5.75e-07	9.73e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—PIK3CA—breast cancer	5.75e-07	9.73e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MAPK8—breast cancer	5.74e-07	9.72e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MAPK3—breast cancer	5.74e-07	9.71e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—AKT1—breast cancer	5.73e-07	9.69e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MDM2—breast cancer	5.73e-07	9.69e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MDM2—breast cancer	5.73e-07	9.69e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—TYMS—breast cancer	5.72e-07	9.68e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—KRAS—breast cancer	5.72e-07	9.67e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—KRAS—breast cancer	5.72e-07	9.67e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—MYC—breast cancer	5.71e-07	9.67e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—MYC—breast cancer	5.71e-07	9.67e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—RAF1—breast cancer	5.71e-07	9.66e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—RAF1—breast cancer	5.71e-07	9.66e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—TGFB1—breast cancer	5.7e-07	9.64e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—TGFB1—breast cancer	5.7e-07	9.64e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—RELA—breast cancer	5.68e-07	9.61e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—RELA—breast cancer	5.68e-07	9.61e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—PIK3CA—breast cancer	5.67e-07	9.59e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—NCOR1—breast cancer	5.65e-07	9.56e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PLA2G4A—breast cancer	5.65e-07	9.56e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GSTM1—breast cancer	5.65e-07	9.56e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCND1—breast cancer	5.65e-07	9.56e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MAPK3—breast cancer	5.65e-07	9.55e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—ERBB2—breast cancer	5.65e-07	9.55e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—ERBB2—breast cancer	5.65e-07	9.55e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—JUN—breast cancer	5.64e-07	9.54e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	5.62e-07	9.5e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	5.6e-07	9.47e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—EGFR—breast cancer	5.59e-07	9.46e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—EGFR—breast cancer	5.59e-07	9.46e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—MYC—breast cancer	5.58e-07	9.44e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MTOR—breast cancer	5.57e-07	9.43e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PIK3CB—breast cancer	5.57e-07	9.43e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MTOR—breast cancer	5.57e-07	9.43e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PIK3CB—breast cancer	5.57e-07	9.43e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TGFB1—breast cancer	5.57e-07	9.42e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CXCL8—breast cancer	5.53e-07	9.36e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—KRAS—breast cancer	5.52e-07	9.34e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—HRAS—breast cancer	5.5e-07	9.3e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—MYC—breast cancer	5.49e-07	9.29e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MMP9—breast cancer	5.49e-07	9.28e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TGFB1—breast cancer	5.48e-07	9.27e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	5.47e-07	9.25e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—EGFR—breast cancer	5.46e-07	9.24e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—KRAS—breast cancer	5.46e-07	9.23e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PTEN—breast cancer	5.45e-07	9.23e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—KRAS—breast cancer	5.45e-07	9.22e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—SRC—breast cancer	5.44e-07	9.21e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—TP53—breast cancer	5.43e-07	9.2e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—PIK3CA—breast cancer	5.43e-07	9.19e-06	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—PIK3CA—breast cancer	5.43e-07	9.19e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—GPX1—breast cancer	5.41e-07	9.16e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CDKN1B—breast cancer	5.4e-07	9.15e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—EGFR—breast cancer	5.37e-07	9.09e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CYP1A1—breast cancer	5.36e-07	9.07e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CXCL8—breast cancer	5.35e-07	9.06e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CXCL8—breast cancer	5.35e-07	9.06e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MAPK8—breast cancer	5.34e-07	9.03e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—AKT1—breast cancer	5.32e-07	9e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—HRAS—breast cancer	5.32e-07	9e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—HRAS—breast cancer	5.32e-07	9e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ERCC2—breast cancer	5.31e-07	8.99e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—VEGFA—breast cancer	5.3e-07	8.97e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CASP3—breast cancer	5.3e-07	8.96e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL2—breast cancer	5.29e-07	8.95e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—KRAS—breast cancer	5.28e-07	8.93e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—KRAS—breast cancer	5.28e-07	8.93e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL6—breast cancer	5.26e-07	8.9e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—PIK3CA—breast cancer	5.25e-07	8.89e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—PIK3CA—breast cancer	5.25e-07	8.89e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—STAT3—breast cancer	5.25e-07	8.88e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CDKN1B—breast cancer	5.23e-07	8.85e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CDKN1B—breast cancer	5.23e-07	8.85e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—HRAS—breast cancer	5.2e-07	8.79e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—KRAS—breast cancer	5.16e-07	8.72e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCND1—breast cancer	5.16e-07	8.72e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—JUN—breast cancer	5.15e-07	8.71e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CASP3—breast cancer	5.12e-07	8.67e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CASP3—breast cancer	5.12e-07	8.67e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL2—breast cancer	5.12e-07	8.66e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL2—breast cancer	5.12e-07	8.66e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CTNNB1—breast cancer	5.11e-07	8.64e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL6—breast cancer	5.09e-07	8.61e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL6—breast cancer	5.09e-07	8.61e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—KRAS—breast cancer	5.07e-07	8.59e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	5.07e-07	8.58e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—SRC—breast cancer	5.06e-07	8.56e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HRAS—breast cancer	5.02e-07	8.5e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MAPK3—breast cancer	5.02e-07	8.49e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—PIK3CA—breast cancer	5.01e-07	8.48e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—PIK3CA—breast cancer	5.01e-07	8.47e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MMP9—breast cancer	5.01e-07	8.47e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—MTHFR—breast cancer	5e-07	8.45e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CDKN1A—breast cancer	4.99e-07	8.44e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCND1—breast cancer	4.99e-07	8.44e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCND1—breast cancer	4.99e-07	8.44e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—JUN—breast cancer	4.98e-07	8.42e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—JUN—breast cancer	4.98e-07	8.42e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PTEN—breast cancer	4.98e-07	8.42e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL6—breast cancer	4.97e-07	8.42e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CTNNB1—breast cancer	4.94e-07	8.36e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CTNNB1—breast cancer	4.94e-07	8.36e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—VEGFA—breast cancer	4.93e-07	8.34e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—TP53—breast cancer	4.91e-07	8.3e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—MYC—breast cancer	4.88e-07	8.25e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—STAT3—breast cancer	4.88e-07	8.25e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MAPK8—breast cancer	4.87e-07	8.24e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TGFB1—breast cancer	4.87e-07	8.23e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HRAS—breast cancer	4.86e-07	8.22e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HRAS—breast cancer	4.86e-07	8.22e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—AKT1—breast cancer	4.86e-07	8.22e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—PIK3CA—breast cancer	4.85e-07	8.21e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—PIK3CA—breast cancer	4.85e-07	8.21e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—TP53—breast cancer	4.84e-07	8.2e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MMP9—breast cancer	4.84e-07	8.19e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MMP9—breast cancer	4.84e-07	8.19e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CDKN1A—breast cancer	4.83e-07	8.16e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CDKN1A—breast cancer	4.83e-07	8.16e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PTEN—breast cancer	4.81e-07	8.15e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PTEN—breast cancer	4.81e-07	8.15e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL6—breast cancer	4.81e-07	8.14e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—EGFR—breast cancer	4.77e-07	8.07e-06	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—AKT1—breast cancer	4.76e-07	8.05e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	4.74e-07	8.02e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MAPK8—breast cancer	4.71e-07	7.97e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MAPK8—breast cancer	4.71e-07	7.97e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—AKT1—breast cancer	4.7e-07	7.95e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—AKT1—breast cancer	4.7e-07	7.95e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—HRAS—breast cancer	4.69e-07	7.94e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	4.66e-07	7.89e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MAPK3—breast cancer	4.66e-07	7.89e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL6—breast cancer	4.65e-07	7.87e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL6—breast cancer	4.65e-07	7.87e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—HRAS—breast cancer	4.64e-07	7.85e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—HRAS—breast cancer	4.63e-07	7.84e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—AKT1—breast cancer	4.63e-07	7.83e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—SRC—breast cancer	4.62e-07	7.81e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—CAV1—breast cancer	4.61e-07	7.8e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—PIK3CA—breast cancer	4.6e-07	7.79e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—AKT1—breast cancer	4.59e-07	7.76e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—TP53—breast cancer	4.58e-07	7.75e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—MYC—breast cancer	4.53e-07	7.67e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TGFB1—breast cancer	4.52e-07	7.65e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—TP53—breast cancer	4.51e-07	7.63e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—KRAS—breast cancer	4.51e-07	7.63e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—VEGFA—breast cancer	4.5e-07	7.61e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL6—breast cancer	4.49e-07	7.6e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—HRAS—breast cancer	4.49e-07	7.59e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—HRAS—breast cancer	4.49e-07	7.59e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—SRC—breast cancer	4.46e-07	7.55e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—SRC—breast cancer	4.46e-07	7.55e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—STAT3—breast cancer	4.45e-07	7.53e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IL6—breast cancer	4.44e-07	7.51e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—AKT1—breast cancer	4.44e-07	7.51e-06	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—AKT1—breast cancer	4.44e-07	7.5e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL6—breast cancer	4.43e-07	7.5e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—EGFR—breast cancer	4.43e-07	7.5e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—HRAS—breast cancer	4.38e-07	7.42e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—VEGFA—breast cancer	4.35e-07	7.36e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—VEGFA—breast cancer	4.35e-07	7.36e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—HRAS—breast cancer	4.31e-07	7.3e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—STAT3—breast cancer	4.31e-07	7.29e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—STAT3—breast cancer	4.31e-07	7.29e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IL6—breast cancer	4.29e-07	7.27e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IL6—breast cancer	4.29e-07	7.27e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—AKT1—breast cancer	4.29e-07	7.26e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—AKT1—breast cancer	4.29e-07	7.26e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MAPK3—breast cancer	4.25e-07	7.2e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—PIK3CA—breast cancer	4.2e-07	7.1e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CG—breast cancer	4.2e-07	7.1e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL6—breast cancer	4.19e-07	7.1e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—KRAS—breast cancer	4.19e-07	7.09e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—AKT1—breast cancer	4.14e-07	7.01e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	4.14e-07	7.01e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—MYC—breast cancer	4.14e-07	7e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL6—breast cancer	4.13e-07	6.99e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TGFB1—breast cancer	4.13e-07	6.98e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MAPK3—breast cancer	4.11e-07	6.96e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MAPK3—breast cancer	4.11e-07	6.96e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—AKT1—breast cancer	4.1e-07	6.93e-06	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—AKT1—breast cancer	4.09e-07	6.92e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—PIK3CA—breast cancer	4.06e-07	6.87e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—PIK3CA—breast cancer	4.06e-07	6.87e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—EGFR—breast cancer	4.05e-07	6.84e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—TP53—breast cancer	4.01e-07	6.78e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—MYC—breast cancer	4e-07	6.77e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—MYC—breast cancer	4e-07	6.77e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TGFB1—breast cancer	3.99e-07	6.75e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TGFB1—breast cancer	3.99e-07	6.75e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—AKT1—breast cancer	3.96e-07	6.7e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—AKT1—breast cancer	3.96e-07	6.7e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—EGFR—breast cancer	3.91e-07	6.62e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—EGFR—breast cancer	3.91e-07	6.62e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—AKT1—breast cancer	3.87e-07	6.55e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	3.85e-07	6.51e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—HRAS—breast cancer	3.83e-07	6.48e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—KRAS—breast cancer	3.82e-07	6.47e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—AKT1—breast cancer	3.81e-07	6.44e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—AKT1—breast cancer	3.76e-07	6.36e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—TP53—breast cancer	3.72e-07	6.3e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—KRAS—breast cancer	3.7e-07	6.26e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—KRAS—breast cancer	3.7e-07	6.26e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CD—breast cancer	3.69e-07	6.24e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6—breast cancer	3.67e-07	6.21e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ALB—breast cancer	3.64e-07	6.16e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—HRAS—breast cancer	3.56e-07	6.02e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—PIK3CA—breast cancer	3.51e-07	5.94e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—NOS3—breast cancer	3.48e-07	5.9e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—AKT1—breast cancer	3.43e-07	5.8e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6—breast cancer	3.41e-07	5.77e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—TP53—breast cancer	3.4e-07	5.75e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—PIK3CA—breast cancer	3.4e-07	5.75e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—PIK3CA—breast cancer	3.4e-07	5.75e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—AKT1—breast cancer	3.38e-07	5.72e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—AKT1—breast cancer	3.32e-07	5.61e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—AKT1—breast cancer	3.32e-07	5.61e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—TP53—breast cancer	3.29e-07	5.56e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—TP53—breast cancer	3.29e-07	5.56e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—HRAS—breast cancer	3.25e-07	5.5e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CB—breast cancer	3.22e-07	5.44e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PTGS2—breast cancer	3.19e-07	5.39e-06	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—AKT1—breast cancer	3.14e-07	5.32e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—HRAS—breast cancer	3.14e-07	5.32e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—HRAS—breast cancer	3.14e-07	5.32e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6—breast cancer	3.11e-07	5.26e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6—breast cancer	3.01e-07	5.09e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6—breast cancer	3.01e-07	5.09e-06	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—AKT1—breast cancer	2.87e-07	4.85e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PTEN—breast cancer	2.78e-07	4.7e-06	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—AKT1—breast cancer	2.77e-07	4.69e-06	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—AKT1—breast cancer	2.77e-07	4.69e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—PIK3CA—breast cancer	1.96e-07	3.32e-06	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AKT1—breast cancer	1.6e-07	2.71e-06	CbGpPWpGaD
